company

FARMACAN AS

3683 NOTODDEN

Return on Equity
74,92 %
Current Ratio
1,27
Debt-to-Equity Ratio
0
Key figures (NOK)2022
Revenue2 694 000
Net Income227 000
Total Assets1 421 000
Total Equity303 000
Income (NOK)2022
Revenue2 694 000
Expenditure2 430 000
Operating Profit263 000
Financial Income0
Financial Costs−27 000
Financial Balance27 000
Earnings Before Tax291 000
Tax64 000
Net Income227 000
Balance (NOK)2022
Total Fixed Assets0
Total Current Assets1 421 000
Total Assets1 421 000
Total Retained Equity273 000
Total Equity303 000
Total Long-Term Debt0
Total Current Debt1 118 000
Total Equity and Debt1 421 000
Cash flow (NOK)2022
Sales Income2 694 000
Other Income0
Revenue2 694 000
Cost of Goods Sold1 665 000
Salary Costs430 000
Depreciation0
Impairment0
Expenditure2 430 000
Operating Profit263 000
Financial Income0
Financial Costs−27 000
Financial Balance27 000
Dividends0
Net Income227 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets0
Real Eastate0
Machinery and Plant Facilities0
Fixtures0
Total Tangible Assets0
Total Fiancial Fixed Assets0
Total Fixed Assets0
Stock312 000
Total Investments0
Cash, Bank0
Total Current Assets1 421 000
Total Assets1 421 000
Total Equity303 000
Short-Term Group Debt0
Total Long-Term Debt0
Creditors−236 000
Unpaid Taxes464 000
Dividends0
Other Current Debt826 000
Total Current Debt1 118 000
Total Equity and Debt1 421 000
Financial indicators2022
Return on Equity74,92 %
Debt-to-Equity Ratio0
Operating Profit Margin9,76 %
Current Ratio1,27
Quick Ratio1,76
Equity Ratio0,21
Gross Profit Margin38,2 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English